The global enteral nutrition market size was valued at $5,661.6 million in 2017, and is projected to reach $10,478.0 million in 2025, registering a CAGR of 7.9% from 2018 to 2025.

Enteral nutrition is administration of drugs or food through the gastrointestinal tract using feeding tubes. It is prescribed to patients who are unable to consume food or take sufficient nutrients orally due to difficulty in swallowing or surgery but has a functional gastrointestinal tract. The enteral nutrients are administered directly into the stomach, duodenum, or jejunum of a patient via enteral pumps and enteral feeding tubes generally, in an operation theatre (OT), intensive care unit (ICU), and critical care unit (CCU), and even at home for critically ill patients. Enteral nutrients are prescribed to patients suffering from chronic illness such as malnutrition, gastrointestinal disorder, cancer, and others.

Rise in prevalence of chronic disorders such as cancer and neurological disorders is key factor driving the growth of the enteral nutrition market. In addition, increase in geriatric population and surge in malnutrition cases have fueled the demand for enteral feeding tubes. Over the years, enteral nutrition has been gaining widespread acceptance, owing to enhancement in techniques, configurations, and ingredients. In addition, low cost and complications associated with enteral nutrition supplement the growth of the enteral nutrition market. However, stringent governmental regulations and inadvertent dislodgment of tubes that could lead to accidental disabilities and death have hampered the market growth. Conversely, development of new technologically advanced products and high market potential in untapped emerging economies are expected to provide lucrative opportunities for the market players in future.

Learn More at :

Enteral nutrition contains macronutrients in the form of isolates of intact proteins, triglycerides, and carbohydrate polymers, which are used for tube feeding to offer complete nutrition. Proteins are required for repairing and maintaining lean body tissues. Protein supplements offer overall, balanced nutrition for long- & short-term tube feeding. Moreover, they help tube-fed patients to gain and maintain normal weight.

They are majorly recommended for malnourished, wound healing, and also patients who are susceptible to pressure ulcers. The enteral nutrition market by protein composition is segmented into standard protein diet, high protein supplement, and protein for diabetes care patient.

North America constituted the highest share in the global enteral feeding devices market, followed by Europe. This is attributed to numerous developments by the key players operating in North America related to enteral nutrition. Asia-Pacific is projected to grow at the highest CAGR, owing to increase in the number of product launches, high demand for enteral nutrition, and increase in awareness toward newly developed enteral feeding & nutrition.

A comprehensive analysis and profiles of major market players, namely Abbott Laboratories, Nestlé S.A., Danone SA, Fresenius Kabi AG, Mead Johnson Nutrition Company, B. Braun Melsungen AG, Global Health Products, Inc., Meiji Holdings Co., Ltd., Victus, Inc., and Hormel Foods Corporation, has been provided in this report.

Learn More :

Author's Bio: 

I am Srushti Helwande. My keen interest in reading and writing. I forayed into the field of writing due to my love for words and the urge to do something different. I have been a part of the content resource team here in Allied Market Research. We have a dedicated team for content development wherein, we coordinate with the Market Analysts and create a precise content. I am personally involved in writing content for user engagement. I owe a responsibility to make sure the content is rich and user-centric. Allied Market Research has given me the chance to gain knowledge about different subjects.